CHA (Updated) Statement About COVID-19 Vaccines

Statement by Sr. Mary Haddad, RSM, President and Chief Executive Officer, 
Catholic Health Association of the United States

"The Catholic Health Association of the United States (CHA) is encouraged that another COVID-19 vaccine developed by Johnson & Johnson has met FDA requirements for emergency use authorization.

"Because COVID-19 has had a disproportionate impact on vulnerable populations, such as the elderly, low-income communities, persons with pre-existing health conditions, and racial and ethnic minorities, CHA believes it is essential that any approved COVID-19 vaccine be distributed in a coordinated and equitable manner.

"Using the guidelines released by the Vatican’s Pontifical Academy for Life in 2005 and 2017 on the origin of vaccines, and the Vatican's December 21, 2020 Note on the morality of using some anti-Covid-19 vaccines, CHA ethicists, in collaboration with other Catholic bioethicists, find it is morally acceptable to receive Covid-19 vaccines developed by Johnson & Johnson, as well as Pfizer and Moderna. CHA encourages Catholic health organizations to distribute the vaccines developed by these companies.

"CHA applauds the work of the scientists who have developed these vaccines and will continue to work to support efforts to educate the public about the importance of getting vaccinated.”

###

The Catholic Health Association of the United States is the national leadership organization of the Catholic health ministry, representing the largest nonprofit provider of health care services in the nation.

  • 1 in 7 patients in the U.S. is cared for in a Catholic hospital each day.
  • Catholic health care, which includes more than 2,200 hospitals, nursing homes, long-term care facilities, systems, sponsors, and related organizations, serves the full continuum of health care across our nation.
» Download PDF

» U.S. Bishop Chairmen for Doctrine and for Pro-Life Address the Use of the Johnson & Johnson COVID-19 Vaccine

Media Contact

For specific media assistance, please contact Richele Keas, Sr. Director, Media Relations.

Media Resources